Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
Clinical trial NCT03962465 · UNKNOWN
Trial details
- NCT number
- NCT03962465
- Sponsor
- University of Virginia
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2023-07-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.